Mind Uncharted Explore. Discover. Learn.
According to a recent report from Transparency Market Research, the global cell culture market was worth USD 10.5 billion in 2023 and is expected to reach USD 27.6 billion by 2031, growing at a projected CAGR of 9.0% between 2023 and 2031. The surge in demand for biologic drugs is the main driver behind the market’s growth, particularly for treating chronic illnesses such as cancer and autoimmune disorders. To produce these drugs, large numbers of cells are required, leading to an increased demand for cell culture products.
The market is also being bolstered by personalized medicine, which requires the production of specific cells for individual patients, as well as advancements in cell culture systems such as 3D cell culture and microfluidic systems. These technologies are more efficient at producing large quantities of cells, including stem cells and immune cells, and are facilitating the production of more complex cell types. Furthermore, the demand for vaccines is also boosting the market share, since vaccine production requires the use of large quantities of cells.
The report also highlights some key findings, such as Sera’s Fetal Bovine Serum (FBS) being the preferred product and the biosimilars and biologic therapeutics segment having the highest market share. The report predicts that Asia Pacific will dominate the market due to the increasing investment in biotechnology and rising demand for biologic drugs in countries like China and India.
Some of the key players in the market mentioned in the report are Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, GE Healthcare, Corning Incorporated, Becton, Dickinson and Company, Merck KGaA, Lonza, VWR International, LLC, and PromoCell GmbH. The report also highlights recent developments from these companies, such as Lonza Group AG launching the XS Paddle, a next-generation single-use mixing system for biopharmaceutical manufacturing, and Thermo Fisher Scientific expanding its Gibco cell culture media offering with the launch of Gibco SFM4CHO, a chemically-defined, animal component-free cell culture medium for the production of recombinant proteins.
Overall, Transparency Market Research offers customized solutions tailored to research requirements, such as analyzing opportunities in various segments based on source, application, demographics, sales channel, and end-use. The firm employs primary and secondary research techniques to provide insights and perspectives on markets to help decision-makers determine growth opportunities in their respective industries.
